https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the importantJune 3, 2025 lead plaintiff deadline. So what: If you purchased Viatris securitiesduring the Class Period you may be entitled […]

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED“) (Nasdaq/AIM:â??HCM; HKEX:â??13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, ranosidenib, fruquintinib and surufatinib, will be presented at the American Society of Clinical Oncology (“ASCO”) Annual Meeting taking place on

GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-38, an novel epigenetic immune activator for cancer immunotherapy. GNTbm-38 was presented as posters at the 2025 American Association of Clinical Oncology (ASCO) Annual Meeting, which is held in Chicago, USA, from May 30 to Jun 04, 2025. Abstract: 2574 Title: Preclinical development of GNTbm-38,

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that an abstract of the research results of the confirmatory Phase II clinical trial of satricabtagene autoleucel (“satri-cel”, CT041) (an autologous CAR T-cell product candidate against protein Claudin18.2) for advanced gastric/gastroesophageal junction cancer (G/GEJC) in China (CT041-ST-01, NCT04581473)

Abstract Released for E7386, Co-Developed Through Collaborative Research Between Eisai and PRISM PRISM BioLab, Co. Ltd. (“PRISM”), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that the analysis of a combination study of E7386(*1), created through collaboration research with Eisai Co., Ltd. (“Eisai”), and Lenvatinib

Poloniex Joins TRM Labs' Beacon Network to Advance Global Efforts Against Crypto Crime GlobeNewswire August 21, 2025 PANAMA CITY, Panama, Aug. 21, 2025 (GLOBE NEWSWIRE) — Poloniex, a global leading crypto exchange, today announced it has become a founding member of the Beacon Network, the first real-time crypto crime response network created by TRM Labs.

Dallas, TX, May 22, 2025 (GLOBE NEWSWIRE) — ZEBRA, the personal care brand founded by clean wellness advocate Jenn Thatcher, has officially expanded into the beauty space with the launch of THE LIP GLOSS – CLEAR, a high-shine, non-toxic gloss designed for long-lasting hydration and a mirror-like finish. This latest launch marks a significant milestone

In a groundbreaking move to elevate clinical diagnostics nationwide, MindHYVE.ai™, a U.S.-based pioneer in orchestrated agentic AI and swarm-intelligent systems, has signed a formal Memorandum of Understanding (MoU) with Islamabad Diagnostic Centre (IDC). The collaboration will see the deployment of Chiron and Ava-AutoNarrator™-two proprietary, AGI-powered agents-across IDC’s core diagnostic workflows. https://mma.prnewswire.com/media/2694515/MindHYVEai_idc.jpg Initially launching at flagship

SYDNEY and HONG KONG, May 22, 2025 (GLOBE NEWSWIRE) — AI-Media Technologies Limited (“AI-Media”), a global leader in live captioning and translation solutions, has entered a groundbreaking partnership with Lightning International (“Lightning”), the leading distributor of Free Ad-Supported Television (FAST) channels. This collaboration aims to break down barriers and bring the joy of entertainment to

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, May 22, 2025 (GLOBE NEWSWIRE) — Reeflex Solutions Inc. (TSXV: RFX) (formerly Bigstack Opportunities I Inc., a capital pool company) (“Reeflex“) is pleased to announce that it has successfully completed its previously announced “Qualifying Transaction” pursuant to TSX Venture